about
Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoniHDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.HDAC Inhibitors Disrupt Programmed Resistance to Apoptosis During Drosophila Development.Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacyRoles of pRB in the Regulation of Nucleosome and Chromatin Structures.The role of transcriptional factor p63 in regulation of epithelial barrier and ciliogenesis of human nasal epithelial cells.YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitorHistone deacetylase inhibitors as cancer therapeutics.Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway.Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53.HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.HDAC2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing.Modulation of antitumor immunity with histone deacetylase inhibitors.p53-Mediated Molecular Control of Autophagy in Tumor Cells.Differences in Functional Expression of Connexin43 and Na1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in HeartThe HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
P2860
Q33602816-6754FD41-6899-43B8-9A82-536605443BE7Q33733042-AB038C18-E9FD-4FD5-ACA5-EE126C7EE771Q33807699-870F9BCD-1359-475C-B4E6-7B5153F0D05FQ38749824-33BB3F93-FF22-4B47-A260-8AF928DAE35EQ39094351-939CAD76-88F1-4EF1-8FC6-E0BA1CFBAD1DQ40052094-8A1DC579-8B6C-40C9-AE93-6EAC37DD0F08Q41093066-A960A938-1757-48BB-B188-90EABD348DA7Q42106883-82D905BD-F57A-495A-BE98-E8B0972D0D86Q47100954-045F57AE-3110-4206-8EA9-68A207EDB1DAQ47136872-67B9F5AE-B834-4136-8345-88A230BDF5C2Q47325071-0B3AAA4F-0EE1-4B70-94D7-55CF1C745E5FQ47687388-B0C69B6C-1126-4F04-A6EB-D4BAF4865C7CQ49557954-EE493FBB-B6B6-4DB0-923F-A1D6A59D19CFQ52645040-A8E6FD89-C19A-4466-8CC7-D5F52655FF4AQ58800432-A31EF0A9-6614-4990-ABB1-91297D8D41F2Q59132751-D4FC3702-1CD7-4AE4-9BE3-FC6A73A125C3
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
How do tumor cells respond to HDAC inhibition?
@en
type
label
How do tumor cells respond to HDAC inhibition?
@en
prefLabel
How do tumor cells respond to HDAC inhibition?
@en
P2093
P2860
P356
P1433
P1476
How do tumor cells respond to HDAC inhibition?
@en
P2093
Andrea Newbold
H Miles Prince
Katrina J Falkenberg
P2860
P304
P356
10.1111/FEBS.13746
P407
P577
2016-04-26T00:00:00Z